The Wisconsin Alumni Research Foundation, known as WARF, learned this week the U.S. Patent and Trademarks Office upheld two of its valuable patents on stem cells. That’s critical for WARF, since it means the foundation can expect to collect huge sums of money on licenses and royalties associated with stem cell lines discovered at the UW.
“This is the center of the universe when it comes to stem cell research. It’s a very exciting area,” said WARF’s managing director Carl Gulbrandsen.